Article info
PDFHepatology
Original research
Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach
- Correspondence to Mathieu Castry, Université de Paris, Inserm, IAME, F-75006 Paris, France; mathieu.castry{at}inserm.fr
Citation
Impact of test-and-treat and risk reduction strategies on HCV transmission among MSM living with HIV in France: a modelling approach
Publication history
- Received May 7, 2020
- Revised September 24, 2020
- Accepted October 2, 2020
- First published October 27, 2020.
Online issue publication
January 23, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.